Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof

Authors

Jin Q. Cheng
Said M. Sebti

Document Type

Patent

Publication Date

March 2014

Patent Number

8673867

Abstract

This application relates to combination therapies including triciribine compounds and epidermal growth factor receptor inhibitor compounds, particularly erlotinib-like compounds and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.

Application Number

13/453,789

Recommended Citation

Cheng, Jin Q. and Sebti, Said M., "Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof" (2014). USF Patents. 94.
https://digitalcommons.usf.edu/usf_patents/94

Assignees

University of South Florida

Filing Date

04/23/2012

Primary/U.S. Class

514/43